TSE:MFC

Manulife Financial (MFC.TO)

60.39
-0.28 (0.46%)
as of Jul 23, 2026, 6:04:18 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
PAST TOP PICK
(A Top Pick Nov 15/04. Up 1.5%.) Not all synergies have been met on the John Hancock deal, so their is still some steam left. Try to buy in the $54 range which would give yoiu a return of 15%.
BUY
His favourite in the insurance industry and the overall financial sector.
BUY
A boring value style dividend paying stock, but where you end up with superior performance because a large portion of your return is from the dividends which are tax effective.
BUY
A good long term growth story in the financial sector. A dominant company in the index. Prefers over the banks.
BUY
Likes this company and the fee revenue they are generating. Probably a higher growth rate than with the banks.
BUY
Manulife and Sun Life have the capacity to increase their dividends more than the banks, which would be a good alternative to the banks.
DON'T BUY
The integration with John Hancock is going quite well. Too expensive. Would prefer 15/20% cheaper. Feels the street is too optimistic about their future profitability.
TOP PICK
Management has done a remarkable job in growing the company.Savings from the John Hancock takeover is going to be $325 million rather than $255 million. Could take over a bank down the road.
BUY
Likes both Sun Life and Manufacturers Life. Both have more room to increase their dividend payout ratio than the Cdn banks.
BUY
Has pulled back a little along with Cdn financials probably due to higher interest rate concerns. Not a bad entry point. Expects 10% upside including dividends. Very solid company.
BUY ON WEAKNESS
A very strong company. Can't see anything in the Eliot Spitzer investigation that will materially impact the company. Has a large US component, so some currency risk. Low $50's is a good entry point.
BUY ON WEAKNESS
Has been caught in a bit of a downdraft because of the bank reports. Asian operations are starting to fire. Wait until the banking reporting season is over and buy on dips.
BUY
Their #1 in the financial sector. Cash flow yield is 16%. Has a good growth potential with their John Hancock acquisition and their Asian activity. Well run.
WATCH
Currently evaluating. John Hancock acquisition was good. Latest quarterly earnings were disappointing. Expensive relative to other insurance companies but has a better growth profile.
BUY
Prefers Manulife over Sun Life as it has a little bit better growth rate. Trading close to its highs. Good international growth.
Showing 1,966 to 1,980 of 2,283 entries